Rare Cancers

An online tool developed by oncologists for this rare diagnosis individualizes survival estimates, resulting in candid discussions and better decision-making.

Study findings from China show that a new treatment option improves survival outcomes in nasopharyngeal carcinoma, but can U.S. populations expect similar results?

A survivor of fibrosarcoma shares his journey through treatment and how he learned to build strength and confidence after the ordeal physically changed his face.

Recently published data support the use of next-generation sequencing as a standard practice in patients with advanced cancer and cancer of an unknown primary location, according to the study’s authors.

On social media, CURE® recently asked its readers with rare cancers what advice they would offer to fellow patients with a similar diagnosis. Here’s what they shared.

A cancer survivor writes about how he, like many, was blindsided by his diagnosis and what it was like to receive treatment for a rare disease: penile cancer.

After a median follow-up of 9.9 months, 38% of the trial participants experienced some degree of tumor shrinkage after receiving Opdivo in combination with Yervoy.

New treatments are needed for penile cancer, but it’s difficult to test drugs in clinical trials because the disease is so uncommon.

A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.

In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.

Salivary cancer is a rare disease that has some of the greatest variances of all types of cancer.

The PAN Foundation today opened a new patient assistance program for people living with carcinoid syndrome.

Two schools of thought exist about how to treat metastatic cancers of unidentified subtype, called carcinomas of unknown primary.

Patients with neuroendocrine tumors have more treatment options than ever before.

Fighting retroperitoneal sarcoma can be like fighting a rare and giant beast.